Anebulo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 22NW, LP | 02/14/2025 | 15.47 M | $25.99 M | 188.23% | 59.64% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 3.04 M | $5.10 M | 494.11% | 11.71% |
| MANGROVE PARTNERS | 02/14/2025 | 2.53 M | $3.64 M | 100.00% | 9.74% |
| LVW ADVISORS, LLC | 01/16/2025 | 632,516 | $1.06 M | -1.33% | 2.44% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 157,720 | $264,971 | -0.09% | 0.61% |
| VANGUARD GROUP INC | 02/11/2025 | 154,036 | $258,780 | 0.00% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 91,341 | $153,495 | 4.04% | 0.35% |
| KING LUTHER CAPITAL MANAGEMENT CORP | 02/07/2025 | 59,662 | $100,232 | 100.00% | 0.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 18,836 | $31,644 | -0.75% | 0.07% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3,929 | $6,601 | 0.61% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 3,326 | $5,588 | 23.46% | 0.01% |
| UBS GROUP AG | 02/14/2025 | 25 | $42 | -96.72% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 9 | $15 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anebulo Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 17 institutional investors and hedge funds held shares of Anebulo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
22NW, LP: 15.47 M
Nantahala Capital Management, LLC: 3.04 M
MANGROVE PARTNERS: 2.53 M
LVW Advisors, LLC: 632,516
Ikarian Capital, LLC: 157,720
VANGUARD GROUP INC: 154,036
87.03% of Anebulo Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 22.55 M shares in the last 24 months. This purchase volume represents approximately $36.54 M in transactions.